ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

THE SUITABILITY OF EXCHANGING ISOTRETINOIN (20MG) FIXED DAY LOW-SERVING ROUTINE WITH ISOTRETINOIN (20MG) DAY LOW-SERVING ROUTINE IN SOFT TO DIRECT SKIN VULGARITIES

AUTHORS:

Dr. Hassaan Ahmed Qureshi, Dr. Muhammad Ahmad, Dr. Muhammad Kamran.

ABSTRACT:

Objective: To examine the appropriateness of exchanging isotretinoin (20mg) fixed day low-serving routine with isotretinoin (20mg) day low-serving routine in soft to direct skin vulgarities. Methods: Sixty soft-to-direct extension patients were separated into two groups, An and B, each with 32 cases. Our current research was led at Services Hospital, Lahore from October 2017 to September 2018. Patients in Group A were given isotretinoin orally at 20mg/day. In Group B patients, isotretinoin 20mg/day was given orally on the exchange days. Both regimens were continued for a period of 6 months. Illness severity was assessed by the Global Acne Grading System. Patients were monitored monthly and their GAGS scores were determined at each visit. The decrease in TAGS score towards the end of the six-month period was considered sufficient. Results: The mean age of case was distinguished to be 21.73±.06 years7. Here remained 5 (8%) male patients, but 57 (94%) were female. The average patient load was 58.89±8.37 kg. In the collection of each daily portion, the mean decrease in GAM levels was 74.96±14.04 while in the collection of the exchange day, the mean decrease in GAM levels was 67.58±15.98 (P>0.06). In the day-to-day data collection, adequacy was achieved in 28 (91%) patients, while in the exchange data collection, viability was recorded in 267 (8.8%) patients (P>0.06). Conclusion: In the administration of vulvar inflammation of soft to direct skin, isotretinoin in the low dose portion of the other day has virtually equivalent adequacy when compared to day by day treatment in the low dose portion. Key words: Acne vulgaris, isotretinoin, efficacy.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.